Researchers from Kyushu University have identified a potential therapeutic target for the treatment of advanced multiple sclerosis (MS), a potentially disabling condition associated with the central nervous system.
Jul 26, 2024
0
21
People with high levels of body fat stored in their belly or arms may be more likely to develop diseases like Alzheimer's and Parkinson's than people with low levels of fat in these areas, according to a study published in ...
Jul 24, 2024
0
37
Cornell researchers have identified a switch that regulates inflammation caused by an immune response, a finding that could one day help clinicians control inflammation-related conditions such as autoimmune, cardiovascular ...
Jul 24, 2024
0
43
A new study conducted at Reichman University's Baruch Ivcher Institute for Brain, Cognition, and Technology, led by Prof. Amir Amedi, demonstrates how the external representation of physiological signals (interoception) can ...
Jul 24, 2024
0
33
A team of researchers at NYU Abu Dhabi, led by Professor Sehamuddin Galadari, has discovered that the tumor suppressor protein Prostate apoptosis response-4 (Par-4) can cause a unique type of cell death called ferroptosis ...
Jul 23, 2024
0
54
People who know more than one language may have a better chance of maintaining their cognitive ability late into life or after neurodegenerative conditions, says an expert at the University of Alberta.
Jul 22, 2024
0
4
Infections and neurodegenerative diseases cause inflammation in the brain. But for unknown reasons, patients with brain inflammation often develop muscle problems that seem to be independent of the central nervous system. ...
Jul 12, 2024
0
203
A multidisciplinary research team has developed a discovery platform to probe the function of genes involved in metabolism—the sum of all life-sustaining chemical reactions.
Jul 8, 2024
0
9
People who are grateful for what they have tend to live longer, a new study reports.
Jul 3, 2024
0
8
Dexamethasone is one of the most important drugs in the treatment of severe COVID-19, but patients respond very differently to the therapy. Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité—Universitätsmedizin ...
Jul 3, 2024
0
100
